Pune/India, April, 2017.
Marketresearchdata.net has added a new report on Middle-East & Africa Antivenom Market. The report predicts the market size of Middle-East & Africa Antivenom Market is expected to reach XX billion by 2021.
The report covers the analysis of global as well as regional markets of Middle-East & Africa Antivenom Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
Middle-East & Africa Antivenom Market Is expected to reach USD 124.2 million by 2021 from USD 89.9 million in 2016, growing at a CAGR of 6.67% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 35,000-55,000 people are recorded with snake bites annually in Africa. To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.
Growing number of venomous animals bite cases, rising demand for antivenom products, emergence of new Pan-African polyvalent antivenom products using modern proteomic & antivenomic tools, and presence of antivenom financing systems are driving the growth of the Middle-East & Africa Antivenom Market. However, dearth of antivenom products, high manufacturing costs of antivenom products, decreasing antivenom production, and limited adoption of antivenom products are hampering the growth of Middle-East & Africa Antivenom Market.
Middle-East & Africa Antivenom is broadly categorized into type and animal. On the basis of type, Middle-East & Africa Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snake, Scorpion, Spider, and Others. Based on geography, Middle-East & Africa Antivenom market is segmented into Middle-East and Africa.
Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
- Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
- Market Segmentation
5.1.3 Hyperimmune Sera
5.1.4 Y-o-Y Growth Analysis, By type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2.6 Y-o-Y Growth Analysis, By Animal
5.2.7 Market Attractiveness Analysis, By Animal
5.2.8 Market Share Analysis, By Animal
- Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
184.108.40.206 By Animal
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
22.214.171.124 By Animal
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
184.108.40.206 By Animal
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders’ Analysis
8.1 Instituto Bioclon, S.A. de C.V.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Pfizer AG
8.3 CSL Limited
8.5 Merck & Co
8.6 Rare Disease Therapeutics, Inc.
8.7 Vins Bioproducts Limited
8.8 BTG Plc
8.9 Incepta Vaccine Ltd
8.10 Bharat Serim and Vaccines Limited (BSV)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
To make an enquiry about report visit:
Reasons to buy this report:
1) Deep insights and comprehensive analysis of global and regional markets
2) Complete coverage of key product types and application segments and their sub-segments through geographies and world market
3) Deep dive into the market share and recent developments of the key players in the industry.
4) Analysis and presentation of evolving market trends, patterns, technological advancements
5) Presentation of market dynamics and factors bearing control over the global and regional markets.
6) Competitive landscapes and insights
7) Opportunity mapping in terms of product developments, research and developments and technological advancements.
To know more about us Visit:
Reasons to choose marketresearchdata.net
1) 24X7 sales support and free analyst time for post purchase queries.
2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry
3) Long term relationship management and exclusivity benefits for our clients
To make sample request for report visit:
USA/Canada Toll Free: +18006380796
Rest of the World: +919765091631